Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

Abstract:
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

Pasadena. CA | Posted on September 1st, 2021

Citi’s 16th Annual BioPharma Virtual Conference – September 8-10, 2021
September 9, 2021 – Arrowhead management will host a day of virtual investor meetings

HC Wainwright 23rd Annual Global Investment Conference – September 13-15, 2021
September 13, 2021 – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation

Baird's 2021 Global Healthcare Conference – September 14-15, 2021
September 14, 2021, 4:55 p.m. ET – Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation

2021 Cantor Virtual Global Healthcare Conference – September 27-30, 2021
September 29, 2021, 9:20 a.m. ET – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation

A copy of the presentation materials and/or live webcast links may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

####

About Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this release except for historical information may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “hope,” “intend,” “plan,” “project,” “could,” “estimate,” or “continue” are intended to identify such forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our business, expectations for our product pipeline or product candidates, including anticipated regulatory submissions and clinical program results, prospects or benefits of our collaborations with other companies, or other characterizations of future events or circumstances are forward-looking statements. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of numerous factors and uncertainties, including the impact of the ongoing COVID-19 pandemic on our business, the safety and efficacy of our product candidates, decisions of regulatory authorities and the timing thereof, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, the enforcement of our intellectual property rights, and the other risks and uncertainties described in our most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other documents filed with the Securities and Exchange Commission from time to time. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Media:
LifeSci Communications, LLC
Josephine Belluardo, Ph.D.
646-751-4361

www.lifescicommunications.com

Copyright © Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

How ultracold, superdense atoms become invisible: A new study confirms that as atoms are chilled and squeezed to extremes, their ability to scatter light is suppressed November 19th, 2021

New microscopy method offers 3D tracking of 100 single molecules at once November 19th, 2021

Two is better than one: Single-atom dimer electrocatalyst for green hydrogen production: Nickel-cobalt metal dimer on nitrogen-doped carbon can catalyze electrolysis under both acidic and basic conditions November 19th, 2021

Nanomedicine

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

'Dancing molecules' successfully repair severe spinal cord injuries: After single injection, paralyzed animals regained ability to walk within four weeks November 12th, 2021

Announcements

Efficient photon upconversion at an organic semiconductor interface November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

New microscopy method offers 3D tracking of 100 single molecules at once November 19th, 2021

Two is better than one: Single-atom dimer electrocatalyst for green hydrogen production: Nickel-cobalt metal dimer on nitrogen-doped carbon can catalyze electrolysis under both acidic and basic conditions November 19th, 2021

Events/Classes

UVA Engineering researchers join quest to demonstrate photonic systems-on-chip: Future applications include faster, more efficient data centers and next-generation millimeter-wave wireless communication July 30th, 2021

Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress June 25th, 2021

NSS Announces Juno Project Scientist Dr. Scott Bolton as a Keynote Speaker at the 2021 Online ISDC: This Year’s Virtual Conference Streams Free to All June 24th, 2021

NSS Fetes JPL’s Rob Manning and Robert Braun at the Online 2021 International Space Development Conference: This Year’s Virtual Conference Streams Free to All Beginning Thursday June 24th, 2021

Nanobiotechnology

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

'Dancing molecules' successfully repair severe spinal cord injuries: After single injection, paralyzed animals regained ability to walk within four weeks November 12th, 2021

Quantum Physics in Proteins: Artificial intelligence affords unprecedented insights into how biomolecules work November 5th, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project